http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20944533

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural
endingPage 55
issn 1662-2685
pageRange 37-55
publicationName Modern trends in pharmacopsychiatry
startingPage 37
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd23225bb8277d80089ba14432de98d3
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_08057158dbe6468e8e4616555b1ca553
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6fdc46d8c6f0d2a4cf92452586b9b7ee
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_df45a69b4d8adfe82dcd3ca133912d31
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9d1ceb784f80fc057fbb55c3ec0b0c73
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc9a521cd0579c4c973d5a4b3a6c8b4f
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_51cc96dc74c6e6ae9878df684abf8f82
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b3bbde678275f7ee1d4e2b89ba29d834
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_af7dc5724090de4dad1201ea0debf1e7
bibliographicCitation Haroon E, Miller AH. Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders. Mod Trends Pharmacopsychiatry. 2017;31():37–55. doi: 10.1159/000470805. PMID: 28738353.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8817-1116
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_570078e54b4caf7c8b5f3dfaaebe2174
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48ddec57bd4fda9e884b1f12d20b34c2
date 2017
identifier https://doi.org/10.1159/000470805
https://pubmed.ncbi.nlm.nih.gov/28738353
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42752
https://portal.issn.org/resource/ISSN/1662-2685
language English
source https://pubmed.ncbi.nlm.nih.gov/
title Inflammation Effects on Glutamate as a Pathway to Neuroprogression in Mood Disorders
discusses http://id.nlm.nih.gov/mesh/M0028010
http://id.nlm.nih.gov/mesh/M0027603
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D019964Q000378
http://id.nlm.nih.gov/mesh/D018698Q000378
http://id.nlm.nih.gov/mesh/D019964Q000276
http://id.nlm.nih.gov/mesh/D007249
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D018450
http://id.nlm.nih.gov/mesh/D018384
http://id.nlm.nih.gov/mesh/D018377
http://id.nlm.nih.gov/mesh/D001921Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14598502
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460544
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4525487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5128032
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10418
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID846

Showing number of triples: 1 to 54 of 54.